GMDP Academy is pleased to announce a newly restructured governance framework, designed to support our mission to advance education in medicines development and pharmaceutical sciences. This strategic realignment strengthens our capacity to serve pharmaceutical physicians and biomedical professionals worldwide, ensuring that our programs remain responsive to industry needs and global standards.
Central to this update is the appointment of a distinguished Board of Directors, composed of seasoned experts whose contributions to biopharmaceuticals, patient-centered care, and regulatory science will enhance the Academy’s direction and impact. This board will guide the strategic vision of the Academy, fostering excellence and innovation in every aspect of our work.
Meet the New Board Members
Estrella Garcia Álvarez
With over 32 years at Almirall, Dr. Estrella Garcia Álvarez has developed extensive expertise in clinical development, particularly in dermatology. Her career has been defined by a commitment to patient-centered research and the successful management of global clinical trials. Her insights into clinical research and international study management will be instrumental as GMDP Academy strengthens its clinical research education.
Federico Grego
A trained economist with over 30 years of experience, Federico Grego brings expertise in both finance and life sciences. He previously led the Allergy Business Unit at LETI Pharma, achieving significant international growth, and has since co-founded several biotech and medtech ventures. Federico’s vision for growth and industry innovation will guide the Academy’s expansion and partnerships.
Kenneth I Kaitin
As a Professor of Medicine and Immunology at Tufts University, Dr. Kaitin has a distinguished career in drug development policy and global pharmaceutical science. His expertise in regulatory science and his involvement with numerous academic institutions will help the Academy deliver industry-leading programs in medicines development.
Pravin Chopra
Dr. Pravin Chopra leads GMDP Academy as CEO with a globally informed, patient-centered approach. His extensive experience in medical affairs and clinical development at leading pharmaceutical companies shapes his commitment to education, ethics, and healthcare equity. Pravin’s leadership will direct the Academy’s strategic focus on advancing impactful education in medicines development.
Roslyn Fleischer Schneider
Dr. Roslyn Schneider is a trailblazer in integrating patient perspectives into biopharmaceutical research and development. With leadership roles in patient advocacy and experience in organizations like Pfizer, she brings an invaluable patient-centered perspective. Her expertise will support GMDP Academy’s mission of promoting a patient-first approach within its programs.
Soneil Guptha
Dr. G, as he is known, has more than 40 years of experience in cardiology and pharmaceutical education. As a co-founding member of the GMDP Academy board, he brings a legacy of dedication to online education and the development of cross-functional teams. His expertise in global medical education will enrich the Academy’s offerings.
Xavier Luria
Formerly the Head of Safety and Efficacy of Medicines at the European Medicines Agency (EMA), Dr. Xavier Luria is a recognized expert in regulatory systems and benefit-risk assessment. His experience as a consultant and educator at institutions across Europe and the USA will strengthen the Academy’s commitment to preparing professionals for the challenges of modern drug development.
A Streamlined Governance Model for Strategic Growth
The Academy’s updated governance model fosters an agile, collaborative structure that aligns closely with industry demands, ensuring our educational programs meet the evolving needs of biomedical professionals. With strategic oversight from the Board of Directors, supported by dedicated leadership roles and committees, this framework strengthens the Academy’s capacity to oversee academic programming, operational efficiency, and quality assurance with precision and foresight.
This governance structure empowers GMDP Academy to adapt swiftly to emerging trends, uphold rigorous standards, and prioritize the success of both students and educators. Through this enhanced model, GMDP Academy is well-positioned for sustainable growth, expanded partnerships, and continued excellence in professional development. As a result, the Academy is better equipped to lead in medicines development education and to serve as a trusted authority in the training of future leaders in biomedical sciences.
